Sandoz Group Ltd (LS:A3ETYB) People

Sandoz Group Ltd

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Craig MarksInvestor Relations · Since at least Apr 2, 2026
David KamenirSenior VP, Strategy and Growth, North America · Since at least Nov 5, 2026
Elisa FiorelloSenior VP, People & Organization · Since at least Nov 5, 2026
Glenn GereckePresident, Generics Manufacturing & Supply · Mar 10, 2026 – Nov 5, 2026 · Past
Jeff BordenSenior VP, Supply Chain NA · Since at least Nov 5, 2026
Jonathan KimballSenior VP, US and Global Public Affairs · Since at least Nov 5, 2026
Katie FischerIR Coordinator · Since at least Apr 2, 2026
Keren HaruviPresident North America · Since at least Aug 5, 2026
Kristen TilakSenior VP and Chief Financial Officer, North America · Since at least Nov 5, 2026
Len ArsenaultSenior VP, Scientific Affairs · Since at least Nov 5, 2026
Leo BronfmanSenior VP, General Counsel North America · Since at least Nov 5, 2026
Martin BickSenior VP, Market Access, Specialty Contracting, & Patient Services · Since at least Nov 5, 2026
Pascal BouyePresident, Generics Manufacturing & Supply · Since at least Jul 15, 2026
Sébastien MénardSenior VP, Head of US Generics · Since at least Nov 5, 2026
Shannon BuhlSenior VP, Commercial Operations · Since at least Nov 5, 2026
Silvia SiegfriedSenior Director, Investor Relations · Since at least Apr 2, 2026
Tamara HacklSenior Director, Investor Relations · Since at least Apr 2, 2026
Ted StueckSenior VP and Chief Ethics, Risk and Compliance Officer · Since at least Nov 5, 2026
Tom OcchipintiSenior VP, Head of US Biosimilar · Since at least Nov 5, 2026
Yannis SkoufalosBoard member · Since at least Nov 5, 2026